Figures & data
Figure 1 Incidence and prevalence rate in dialysis treatment. Data from the Uruguayan Dialysis Registry.
![Figure 1 Incidence and prevalence rate in dialysis treatment. Data from the Uruguayan Dialysis Registry.](/cms/asset/44ace98a-316a-4d03-b015-ee750d00083e/irnf_a_192484_uf0001_b.gif)
Table 1 ESRD incident rates by time periods by diagnoses, per million population (pmp). From the Uruguayan Dialysis Registry
Figure 2 Annual incidence of ESRD secondary to diabetic nephropathy by time periods (95% confidence interval). Data from the Uruguayan Dialysis Registry.
![Figure 2 Annual incidence of ESRD secondary to diabetic nephropathy by time periods (95% confidence interval). Data from the Uruguayan Dialysis Registry.](/cms/asset/332bc71d-af2f-47ce-b2f8-d2717954046d/irnf_a_192484_uf0002_b.gif)
Table 2 Relative risk of ESRD, adjusted for confounding factors. From the Uruguayan Registry of Glomerulonephritis
Table 3 Indicators to evaluate the Prevention Program. Data from the Uruguayan Registry of Glomerulonephritis
Figure 3 Relative risk of end stage renal disease in the first three months of Registry. Data adjusted for age, gender, diagnosis, and initial serum creatinine. Data from the Uruguayan Registry of Glomerulonephritis.
![Figure 3 Relative risk of end stage renal disease in the first three months of Registry. Data adjusted for age, gender, diagnosis, and initial serum creatinine. Data from the Uruguayan Registry of Glomerulonephritis.](/cms/asset/84160095-4459-48a9-b2bf-11356463bd58/irnf_a_192484_uf0003_b.gif)
Table 4 Patient characteristics at the first consultation., from the Registry of Chronic Kidney Disease. Pilot Program of Renal Healthcare of Montevideo
Table 5 Analysis of three months follow-up data, from the Registry of Chronic Kidney Disease. Pilot Program of Renal Healthcare of Montevideo